KM Research Hub

LITERATURE

原始候选快照

v3 复核前的候选池,完整保留,仅供查看,不会自动重新处理。 共 7004 篇。

导出 CSV
论文标识日期入排置信度入排依据KM 状态
Short-term Outcomes in Infants after General Anesthesia with Low-dose Sevoflurane/Dexmedetomidine/Remifentanil versus Standard-dose Sevoflurane (the TREX Trial).AnesthesiologyPMID 39283983无 PMCID2024-Dec-010.98未发现恶性肿瘤人群证据。待处理
The impact of mepolizumab on sleep impairment in CRSwNP: post hoc analyses of SYNAPSE and MUSCA.RhinologyPMID 39323188无 PMCID2024-Dec-010.98未发现恶性肿瘤人群证据。待处理
Upadacitinib in Adolescents With Moderate to Severe Atopic Dermatitis: Analysis of 3 Phase 3 Randomized Clinical Trials Through 76 Weeks.JAMA DermatolPMID 39441580PMC115815052024-Dec-010.98未发现恶性肿瘤人群证据。待处理
Efficacy of Adding Veliparib to Temozolomide for Patients With MGMT-Methylated Glioblastoma: A Randomized Clinical Trial.JAMA OncolPMID 39480453PMC115283412024-Dec-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。已完成
Triple-Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Moderate-to-Severe Acne in Children and Adolescents.J Drugs DermatolPMID 39630680无 PMCID2024-Dec-010.98未发现恶性肿瘤人群证据。待处理
Efficacy and Safety of Nefecon in Patients with IgA Nephropathy from Mainland China: 2-Year NefIgArd Trial Results.Kidney360PMID 39724565PMC116879892024-Dec-010.98未发现恶性肿瘤人群证据。待处理
Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory diffuse large B-cell lymphoma: A phase III bridging study in Chinese patients.J Cancer Res Ther疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。PMID 39792424无 PMCID2024-Dec-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。无 KM 图
Efficacy and Safety of Topical Solution of Diperoxochloric Acid for Neuropathic Diabetic Foot Ulcer: Results from a Phase 3, Multicentre, Randomized, Active-controlled, Parallel-group Study.Int J Low Extrem WoundsPMID 35275009无 PMCID2024-Dec0.98未发现恶性肿瘤人群证据。待处理
Metoclopramide Nasal Spray in Women With Symptomatic Diabetic Gastroparesis: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.Clin Gastroenterol HepatolPMID 37924856无 PMCID2024-Dec0.98未发现恶性肿瘤人群证据。待处理
The Efficacy of Tradipitant in Patients With Diabetic and Idiopathic Gastroparesis in a Phase 3 Randomized Placebo-Controlled Clinical Trial.Clin Gastroenterol HepatolPMID 38237696无 PMCID2024-Dec0.98未发现恶性肿瘤人群证据。待处理
A Study of Safety and Effectiveness of Evicel Fibrin Sealant as an Adjunctive Hemostat in Pediatric Surgery.Eur J Pediatr SurgPMID 38552641PMC115377222024-Dec0.98未发现恶性肿瘤人群证据。待处理
Tolerability of Olaparib Combined with Abiraterone in Patients with Metastatic Castration-resistant Prostate Cancer: Further Results from the Phase 3 PROpel Trial.Eur Urol Oncol疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。PMID 38582650无 PMCID2024-Dec0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。无 KM 图
Efficacy of risankizumab across subgroups in patients with active psoriatic arthritis: a post hoc integrated analysis of the phase 3 KEEPsAKE 1 and KEEPsAKE 2 randomized controlled trials.J Dermatolog TreatPMID 38632977无 PMCID2024-Dec0.98未发现恶性肿瘤人群证据。待处理
Lebrikizumab monotherapy impacts on quality of life scores through improved itch and sleep interference in two Phase 3 trials.J Dermatolog TreatPMID 38679419无 PMCID2024-Dec0.98未发现恶性肿瘤人群证据。待处理
Rapid and sustained improvements in itch and quality of life with upadacitinib plus topical corticosteroids in adults and adolescents with atopic dermatitis: 52-week outcomes from the phase 3 AD Up study.J Dermatolog TreatPMID 38697950无 PMCID2024-Dec0.98未发现恶性肿瘤人群证据。待处理
Efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: 16-week results from three randomized phase 3 clinical trials.J Dermatolog TreatPMID 38735650无 PMCID2024-Dec0.98未发现恶性肿瘤人群证据。待处理
Comparison of Los Angeles Grades of Erosive Esophagitis Scored by Local Investigators vs Central Adjudicators in a Clinical Trial.Clin Gastroenterol HepatolPMID 38777170无 PMCID2024-Dec0.98未发现恶性肿瘤人群证据。待处理
The safety, immunogenicity, and efficacy of heterologous boosting with a SARS-CoV-2 mRNA vaccine (SYS6006) in Chinese participants aged 18 years or more: a randomized, open-label, active-controlled phase 3 trial.Emerg Microbes InfectPMID 38860446PMC109061272024-Dec0.98未发现恶性肿瘤人群证据。待处理
A multicenter, double-blind, randomized, parallel-group, active-controlled, phase 3 clinical trial to compare the effectiveness and safety of two botulinum toxin type A formulations for improving moderate to severe glabellar wrinkles in Asians.J Dermatolog TreatPMID 38880494无 PMCID2024-Dec0.98未发现恶性肿瘤人群证据。待处理
Supplemental Intravitreal Ranibizumab Injections in Eyes Treated with the Port Delivery System with Ranibizumab in the Archway Trial.Ophthalmol RetinaPMID 38914294无 PMCID2024-Dec0.98未发现恶性肿瘤人群证据。待处理
Biosimilar Candidate CT-P42 in Diabetic Macular Edema: 24-Week Results from a Randomized, Active-Controlled, Phase III Study.Ophthalmol RetinaPMID 38942386无 PMCID2024-Dec0.98未发现恶性肿瘤人群证据。待处理
Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials.J Dermatolog TreatPMID 38945549无 PMCID2024-Dec0.98未发现恶性肿瘤人群证据。待处理
Efficacy, tolerability, and bone density outcomes of elagolix with add-back therapy for endometriosis-associated pain: twelve months of an ongoing randomized phase 3 trial.Am J Obstet GynecolPMID 38955323无 PMCID2024-Dec0.98未发现恶性肿瘤人群证据。待处理
Adjuvant Atezolizumab in Patients with Sarcomatoid Renal Cell Carcinoma: A Prespecified Subgroup Analysis of IMmotion010.Eur Urol OncolPMID 38955577无 PMCID2024-Dec0.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Hormone-related side effects in new users of a levonorgestrel 52-mg intrauterine device.Am J Obstet GynecolPMID 38969201无 PMCID2024-Dec0.98未发现恶性肿瘤人群证据。待处理
Topical Cannabidiol for Established Chemotherapy-Induced Neuropathy: A Pilot Randomized Placebo-Controlled Trial.Cannabis Cannabinoid ResPMID 39016024PMC116852982024-Dec0.85The study is an oncology-related randomized trial with a drug intervention and reports original results, but it is explicitly a pilot trial (not Phase III/IIIb or definitive Phase II/III) and does not have a time-to-event efficacy endpoint.待处理
Long-term prevention of hereditary angioedema attacks with lanadelumab in adolescents.Ann Allergy Asthma ImmunolPMID 39128590无 PMCID2024-Dec0.98未发现恶性肿瘤人群证据。待处理
Inhaled Nitric Oxide in Fibrotic Lung Disease: A Randomized, Double-Blind, Placebo-controlled Trial.Ann Am Thorac SocPMID 39141673无 PMCID2024-Dec0.98未发现恶性肿瘤人群证据。待处理
Characterization and natural history of patients with LMNA-related dilated cardiomyopathy in the phase 3 REALM-DCM trial.ESC Heart FailPMID 39145700PMC116313082024-Dec0.98未发现恶性肿瘤人群证据。待处理
Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting: Final Results of a Randomized, Placebo-Controlled, Phase II/III Trial.J Clin OncolPMID 39151115PMC116085912024-Dec0.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Dupilumab response onset, maintenance, and durability in patients with severe CRSwNP.J Allergy Clin ImmunolPMID 39151476无 PMCID2024-Dec0.98未发现恶性肿瘤人群证据。待处理
A phase 3, randomized, double-blind, sham-controlled trial of SI-6603 (condoliase) in patients with radicular leg pain associated with lumbar disc herniation.Spine JPMID 39168360无 PMCID2024-Dec0.98未发现恶性肿瘤人群证据。待处理
Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR-Mutant, Metastatic Nonsquamous Non-Small Cell Lung Cancer.J Clin OncolPMID 39173098PMC116085962024-Dec0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。已完成
A randomized phase 3b study evaluating the safety and efficacy of risankizumab in adult patients with moderate-to-severe plaque psoriasis with non-pustular palmoplantar involvement.J Am Acad DermatolPMID 39208985无 PMCID2024-Dec0.98未发现恶性肿瘤人群证据。待处理
Dupilumab Efficacy in Children With Type 2 Asthma Receiving High- to Medium-Dose Inhaled Corticosteroids (VOYAGE).J Allergy Clin Immunol PractPMID 39209068无 PMCID2024-Dec0.98未发现恶性肿瘤人群证据。待处理
Changes in REVEAL Lite 2 risk status are associated with long-term outcomes in patients with pulmonary arterial hypertension: A post-hoc analysis of the GRIPHON study.J Heart Lung TransplantPMID 39222737无 PMCID2024-Dec0.98未发现恶性肿瘤人群证据。待处理
A randomized study of 6 versus 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse.Ann Oncol疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。PMID 39241959无 PMCID2024-Dec1.00命中用户提供的消化道肿瘤阳性参考集。无 KM 图
Gemcitabine, carboplatin, and Epstein-Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trial.Ann Oncol疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。PMID 39241963无 PMCID2024-Dec0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。无 KM 图
Association of Declining Prostate-specific Antigen Levels with Clinical Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Receiving [177Lu]Lu-PSMA-617 in the Phase 3 VISION Trial.Eur UrolPMID 39242323PMC128880412024-Dec0.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Cost per responder analysis of abrocitinib versus dupilumab in moderate to severe atopic dermatitis.Ital J Dermatol VenerolPMID 39250163无 PMCID2024-Dec0.98未发现恶性肿瘤人群证据。待处理
Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer: Results of the PACE-A Randomised Trial.Eur UrolPMID 39266383无 PMCID2024-Dec0.90The record describes a Phase III randomized trial in prostate cancer, but it compares two non-drug interventions (prostatectomy vs. stereotactic radiotherapy) and does not report a time-to-event efficacy endpoint; primary outcomes are patient-reported quality of life metrics.待处理
Efficacy and safety of recombinant human thrombopoietin for the treatment of chronic primary immune thrombocytopenia in children and adolescents: A multicentre, randomized, double-blind, placebo-controlled phase III trial.Br J HaematolPMID 39267281无 PMCID2024-Dec0.98未发现恶性肿瘤人群证据。待处理
A Streamlined Strategy for Basophil Activation Testing in a Multicenter Phase III Clinical Trial.J Allergy Clin Immunol PractPMID 39284563无 PMCID2024-Dec0.98未发现恶性肿瘤人群证据。待处理
Osimertinib after definitive chemoradiotherapy in unresectable stage III epidermal growth factor receptor-mutated non-small-cell lung cancer: analyses of central nervous system efficacy and distant progression from the phase III LAURA study.Ann Oncol疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。PMID 39289145无 PMCID2024-Dec0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。无 KM 图
Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase III KEYNOTE-006 study.Ann Oncol疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。PMID 39306585无 PMCID2024-Dec0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。无 KM 图
5-Fluorouracil metabolic pathway genes predict recurrence risk following adjuvant S-1 therapy: Results of an ancillary analysis from a phase III trial of resected biliary tract cancer (JCOG1202A1).J Hepatobiliary Pancreat Sci疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。PMID 39318258无 PMCID2024-Dec0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。无 KM 图
Efficacy of once-nightly sodium oxybate (FT218) on daytime symptoms in individuals with narcolepsy with or without concomitant alerting agent use: A post hoc analysis from the phase 3 REST-ON trial.Sleep MedPMID 39321628无 PMCID2024-Dec0.98未发现恶性肿瘤人群证据。待处理
Eight-year efficacy and safety of tenofovir alafenamide for treatment of chronic hepatitis B virus infection: Final results from two randomised phase 3 trials.Aliment Pharmacol TherPMID 39327857PMC115997882024-Dec0.98未发现恶性肿瘤人群证据。待处理
Patiromer for Heart Failure Medication Optimization in Patients With Current or Past Hyperkalemia: DIAMOND Subanalysis.JACC Heart FailPMID 39340493无 PMCID2024-Dec0.98未发现恶性肿瘤人群证据。待处理
DaxibotulinumtoxinA for injection to treat moderate or severe glabellar lines: A randomized, multicenter, Phase III, double-blind, placebo-controlled trial in China.J Plast Reconstr Aesthet SurgPMID 39353286无 PMCID2024-Dec0.98未发现恶性肿瘤人群证据。待处理